DRUG DISCOVERY
AI-Driven Drug Discovery Revolutionizes Treatment Development
AI's integration into drug discovery is transforming the development of treatments, reducing time and cost significantly, according to NVIDIA's blog.
NVIDIA's GPU Innovations Revolutionize Drug Discovery Simulations
NVIDIA's latest GPU optimization techniques, including CUDA Graphs and C++ coroutines, promise to accelerate pharmaceutical research by enhancing molecular dynamics simulations.
Yale, Moderna, and NVIDIA Harness Quantum Computing for Drug Discovery
Yale, Moderna, and NVIDIA explore quantum machine learning to enhance drug discovery. The collaboration focuses on GPU-accelerated simulation of quantum algorithms for predicting molecular properties.
Montai Therapeutics Leverages NVIDIA NIM for Multimodal AI Drug Discovery
Montai Therapeutics collaborates with NVIDIA to develop a multimodal AI platform for drug discovery using NVIDIA NIM microservices.
NVIDIA's NIM Agent Blueprint Transforms Drug Discovery with AI-Driven Virtual Screening
NVIDIA's NIM Agent Blueprint leverages generative AI for faster, cost-effective drug discovery, enhancing hit-to-lead transitions.
AI-Driven Molecular De-Extinction: A New Frontier in Combating Drug-Resistant Pathogens
Researchers are using AI to resurrect DNA from extinct species to combat drug-resistant pathogens, potentially revolutionizing antibiotic discovery.
Quantum Mechanics Bolsters Drug Discovery with QUELO-G and CUDA Graphs
Quantum mechanics is enhancing drug discovery through the use of QUELO-G and CUDA graphs.